These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9573231)

  • 1. Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation.
    Gaur M; Leavitt AD
    J Virol; 1998 Jun; 72(6):4678-85. PubMed ID: 9573231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.
    Leavitt AD; Robles G; Alesandro N; Varmus HE
    J Virol; 1996 Feb; 70(2):721-8. PubMed ID: 8551608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.
    Tsurutani N; Kubo M; Maeda Y; Ohashi T; Yamamoto N; Kannagi M; Masuda T
    J Virol; 2000 May; 74(10):4795-806. PubMed ID: 10775618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions.
    Gerton JL; Ohgi S; Olsen M; DeRisi J; Brown PO
    J Virol; 1998 Jun; 72(6):5046-55. PubMed ID: 9573274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells.
    LaFemina RL; Schneider CL; Robbins HL; Callahan PL; LeGrow K; Roth E; Schleif WA; Emini EA
    J Virol; 1992 Dec; 66(12):7414-9. PubMed ID: 1433523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration.
    Chen H; Engelman A
    J Virol; 2000 Sep; 74(17):8188-93. PubMed ID: 10933731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells.
    Sinha S; Grandgenett DP
    J Virol; 2005 Jul; 79(13):8208-16. PubMed ID: 15956566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.
    Li X; Koh Y; Engelman A
    J Virol; 2012 Apr; 86(7):3861-79. PubMed ID: 22278243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells.
    Wiskerchen M; Muesing MA
    J Virol; 1995 Jan; 69(1):376-86. PubMed ID: 7983732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion of the lethal phenotype of an HIV-1 integrase mutant virus by overexpression of the same integrase mutant protein.
    Priet S; Navarro JM; Quérat G; Sire J
    J Biol Chem; 2003 Jun; 278(23):20724-30. PubMed ID: 12670953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
    Engelman A; Englund G; Orenstein JM; Martin MA; Craigie R
    J Virol; 1995 May; 69(5):2729-36. PubMed ID: 7535863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.
    Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
    PLoS One; 2009; 4(1):e4155. PubMed ID: 19127291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
    Masuda T; Planelles V; Krogstad P; Chen IS
    J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.
    Chen SS; Lee SF; Hao HJ; Chuang CK
    J Virol; 1998 Jun; 72(6):4765-74. PubMed ID: 9573241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.
    Cannon PM; Wilson W; Byles E; Kingsman SM; Kingsman AJ
    J Virol; 1994 Aug; 68(8):4768-75. PubMed ID: 8035478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of integrase function in HIV-1 virions.
    Fletcher TM; Soares MA; McPhearson S; Hui H; Wiskerchen M; Muesing MA; Shaw GM; Leavitt AD; Boeke JD; Hahn BH
    EMBO J; 1997 Aug; 16(16):5123-38. PubMed ID: 9305653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
    Liu H; Wu X; Xiao H; Conway JA; Kappes JC
    J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations altering acetylated residues in the CTD of HIV-1 integrase cause defects in proviral transcription at early times after integration of viral DNA.
    Winans S; Goff SP
    PLoS Pathog; 2020 Dec; 16(12):e1009147. PubMed ID: 33351861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors.
    Sinha S; Pursley MH; Grandgenett DP
    J Virol; 2002 Apr; 76(7):3105-13. PubMed ID: 11884535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations.
    Varadarajan J; McWilliams MJ; Hughes SH
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14747-52. PubMed ID: 23959861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.